Paper34697307
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope.
Abernathy ME and 11 others. NPJ Vaccines, 2021. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope. Papers, record 34697307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34697307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 AI100148 | NIAID NIH HHS | United States | P01AI100148 | PubMed and NIH | NIH RePORTER |
| CAVD INV-002143 | Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) | PubMed | PubMed | ||
| K99 AI140770 | NIAID NIH HHS | United States | K99AI140770 | PubMed | NIH RePORTER |
| R00 AI140770 | NIAID NIH HHS | United States | R00AI140770 | PubMed | NIH RePORTER |
| #OPP1146996 | Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) | PubMed | PubMed | ||
| HIVRAD P01 AI100148 | Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) | PubMed | PubMed | ||
| INV-002143 | Gates Foundation | United States | PubMed | PubMed | |
| INV-002143 | Gates Foundation | United States | PubMed | PubMed | |
| P50 AI150464 | NIAID NIH HHS | United States | P50AI150464 | PubMed and NIH | NIH RePORTER |
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29775847 | Strategies for a multi-stage neutralizing antibody-based HIV vaccine. | Curr Opin Immunol | 2018 | https://conductscience.org/library/papers/29775847 | PubMed |
| 2 | 28003309 | Progress toward active or passive HIV-1 vaccination. | J Exp Med | 2017 | https://conductscience.org/library/papers/28003309 | PubMed |
| 3 | 29768174 | HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure. | Immunity | 2018 | https://conductscience.org/library/papers/29768174 | PubMed |
| 4 | 31142836 | Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. | Nature | 2019 | https://conductscience.org/library/papers/31142836 | PubMed |
| 5 | 31672916 | A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. | Science | 2019 | https://conductscience.org/library/papers/31672916 | PubMed |
| 6 | 27174988 | Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. | Science | 2016 | https://conductscience.org/library/papers/27174988 | PubMed |
| 7 | 29867235 | Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. | Nat Med | 2018 | https://conductscience.org/library/papers/29867235 | PubMed |
| 8 | 23539181 | Rational HIV immunogen design to target specific germline B cell receptors. | Science | 2013 | https://conductscience.org/library/papers/23539181 | PubMed |
| 9 | 30097292 | Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization. | Immunity | 2018 | https://conductscience.org/library/papers/30097292 | PubMed |
| 10 | 27545891 | Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies. | Cell Rep | 2016 | https://conductscience.org/library/papers/27545891 | PubMed |
| 11 | 24068931 | A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/24068931 | PubMed |
| 12 | 31866284 | Isolation of single HIV-1 Envelope specific B cells and antibody cloning from immunized rhesus macaques. | J Immunol Methods | 2020 | https://conductscience.org/library/papers/31866284 | PubMed |
| 13 | 25296255 | Structure and immune recognition of trimeric pre-fusion HIV-1 Env. | Nature | 2014 | https://conductscience.org/library/papers/25296255 | PubMed |
| 14 | 27168247 | Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. | Annu Rev Immunol | 2016 | https://conductscience.org/library/papers/27168247 | PubMed |
| 15 | 27617678 | HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies. | Immunity | 2016 | https://conductscience.org/library/papers/27617678 | PubMed |
| 16 | 30076101 | Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies. | Immunity | 2018 | https://conductscience.org/library/papers/30076101 | PubMed |
| 17 | 9200464 | Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. | J Immunol | 1997 | https://conductscience.org/library/papers/9200464 | PubMed |
| 18 | 29474444 | Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. | PLoS Pathog | 2018 | https://conductscience.org/library/papers/29474444 | PubMed |
| 19 | 26781591 | Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization. | Sci Rep | 2016 | https://conductscience.org/library/papers/26781591 | PubMed |
| 20 | 22366317 | Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22366317 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 37993719 | Intermediate conformations of CD4-bound HIV-1 Env heterotrimers. | Nature | 2023 | https://conductscience.org/library/papers/37993719 |
Source PubMed
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34697307
GET https://conductscience.org/api/papers/v1/34697307/references?page=2